Detalles de la búsqueda
1.
Determinants of active surveillance uptake in a diverse population-based cohort of men with low-risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS).
Cancer
; 130(10): 1797-1806, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38247317
2.
Can MRI Help Inform Which Men With a History of Multifocal High-Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation Remain at an Elevated Risk for Clinically Significant Prostate Cancer?
J Urol
; 211(2): 234-240, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37930976
3.
Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillance.
Prostate
; 83(12): 1141-1149, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37173808
4.
The Use and Short-term Outcomes of Active Surveillance in Men With National Comprehensive Cancer Network Favorable Intermediate-risk Prostate Cancer: The Initial Michigan Urological Surgery Improvement Collaborative Experience.
J Urol
; 209(1): 170-179, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36265120
5.
The added influence of genomics and post-MRI confirmatory biopsy results to MRI results alone on medical decision making for men with favorable risk prostate cancer being considered for active surveillance.
Prostate
; 82(10): 1068-1074, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35468226
6.
Delayed radical prostatectomy after a period of active surveillance is not associated with the use of secondary treatments compared with immediate prostatectomy.
Prostate
; 82(3): 323-329, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34855239
7.
Delayed Radical Prostatectomy is Not Associated with Adverse Oncologic Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic.
J Urol
; 204(4): 720-725, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32356508
8.
Confirmatory Magnetic Resonance Imaging with or without Biopsy Impacts Decision Making in Newly Diagnosed Favorable Risk Prostate Cancer.
J Urol
; 201(5): 923-928, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30694939
9.
TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model.
BMC Cancer
; 19(1): 972, 2019 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31638934
10.
Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance.
BJU Int
; 123(5): 846-853, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30248225
11.
Reply by Authors.
J Urol
; 209(1): 178-179, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36268990
12.
Observation versus treatment among men with favorable risk prostate cancer in a community-based integrated health care system: a retrospective cohort study.
BMC Urol
; 18(1): 55, 2018 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29866100
13.
Avoidance of androgen deprivation therapy in radiorecurrent prostate cancer as a clinically meaningful endpoint for salvage cryoablation.
Prostate
; 77(14): 1446-1450, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28856702
14.
Appropriateness Criteria for Active Surveillance of Prostate Cancer.
J Urol
; 197(1): 67-74, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27422298
15.
Prostate cancer family history and eligibility for active surveillance: a systematic review of the literature.
BJU Int
; 120(4): 464-467, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28371016
16.
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis.
Mol Cancer
; 15(1): 68, 2016 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27809841
17.
Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.
J Transl Med
; 14: 72, 2016 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26975354
18.
Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Reply.
J Urol
; 206(1): 172-173, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33818132
19.
Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.
Int J Cancer
; 136(1): 11-20, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24798488
20.
Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience.
J Urol
; 204(6): 1119-1121, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32717165